Emerging Research in Prostate Cancer Imaging — September 2024

News
Slideshow

Catch up on the most-well viewed prostate imaging content in September 2024.

Touching on a variety of topics in prostate cancer imaging, ranging from Phase 3 trial results for 177Lu-PSMA-617 in taxane-naïve patients with mCRPC to a new meta-analysis comparing PSMA PET/CT to mpMRI in detecting biomechanical recurrence of PCa, here are the top five most well-viewed prostate imaging content from Diagnostic Imaging for September 2024.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
Current Perspectives on Prostate Cancer and Emerging Theranostic Agents, Part 1
Diagnostic Imaging’s Weekly Scan: September 28 — October 4
MRI Research Shows ‘Virtually Complete Abrogation’ of New Lesions with Switch to Ofatumumab for Multiple Sclerosis Patients
© 2025 MJH Life Sciences

All rights reserved.